Valeo Pharma Inc. (VPHIF)
OTCMKTS · Delayed Price · Currency is USD
0.0469
-0.0471 (-50.11%)
At close: Aug 29, 2024
Valeo Pharma Market Cap
Valeo Pharma has a market cap or net worth of $4.63 million as of September 26, 2025. Its market cap has decreased by -90.37% in one year.
Market Cap
4.63M
Enterprise Value
49.22M
Revenue
38.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since September 23, 2020, Valeo Pharma's market cap has decreased from 53.11M to 4.63M, a decrease of -91.29%. That is a compound annual growth rate of -46.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2024 | 4.63M | -66.50% |
| Dec 29, 2023 | 13.81M | -59.55% |
| Dec 29, 2022 | 34.15M | -24.96% |
| Dec 31, 2021 | 45.51M | -27.02% |
| Dec 31, 2020 | 62.37M | 17.42% |
| Sep 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 721.78M |
| Tian'an Technology Group | 718.73M |
| Elite Pharmaceuticals | 670.79M |
| Glass House Brands | 518.99M |
| Northwest Biotherapeutics | 377.99M |
| CytoDyn | 345.51M |
| American Oncology Network | 308.52M |
| Nika Pharmaceuticals | 301.74M |